Osteoporosis in men with chronic obstructive pulmonary disease. Utility of phalangeal densitometry (AccuDEXA) as a screening method;Osteoporosis en el varón con enfermedad pulmonar obstructiva crónica. Utilidad de la densitometría de falange (AccuDEXA) como método de cribado diagnóstico

Reumatologia Clinica

Volumn 1, Issue 1, 2005, Pages 7-11

  Casado, E ^a   Larrosa, M ^a   Naval, E ^b   Gallego, M ^b   Gomez A ^a   Domingo, C ^b   Gratacos J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

Author keywords

Bone densitometry; COPD; Osteoporosis; Phalanx

Indexed keywords

EID: 33745498735     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(05)72706-6     Document Type: Article

References (18)

1. NIH Consensus Conference. Osteoporosis prevention, diagnosis, and therapy. JAMA 285 (2001) 785-795
2. Walker-Bone K., Dennison E., and Cooper C. Epidemiology of osteoporosis. Rheum Dis Clin North Am 27 (2001) 1-18
3. Cummings S.R., Black D.M., Nevitt M.C., Browner W., Cauley J., Ensrud K., et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341 (1993) 72-75
4. Andreassen H., and Vestbo J. Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur Respir J Suppl 46 (2003) 2s-4s
5. Ionescu A.A., and Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 46 (2003) 64s-75s
6. Papaioannou A., Parkinson W., Ferko N., Probyn L., Ionnidis G., Jurriaans E., et al. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporosis Int 14 (2003) 913-917
7. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report Series 843 (1994), WHO, Geneva
8. Karadag F., Cildag O., Yurekli Y., and Gurgey O. Should COPD patients be routinely evaluated for bone mineral density?. J Bone Miner Metab 21 (2003) 242-246
9. Sin D.D., Man J.P., and Man S.F. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 114 (2003) 10-14
10. Biskobing D.M. COPD and osteoporosis. Chest 121 (2002) 609-620
11. Adler R.A., and Hochbberg M.C. Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Departmetn of Veterans Affairs. Arch Intern Med 163 (2003) 2619-2624
12. Van Staa T.P., Leufkens H.G.M., and Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int 14 (2002) 777-787
13. Danés I., and Bosch M. Cómo se puede prevenir y tratar la osteoporosis inducida por glucocorticoides. Med Clin (Barc) 120 (2003) 473-475
14. Steinbuch M., Youket T.E., and Cohen S. Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporosis Int 15 (2004) 323-328
15. Mulder J.E., Michaeli D., Flaster E.R., and Siris E. Comparison of bone mineral density of the phalanges, lumbar spine, hip, and forearm for assessment of osteoporosis in postmenopausal women. J Clin Densitom 3 (2000) 373-381
16. Fiter J., Nolla J.M., Gómez-Vaquero C., Martínez-Aguilà D., Valverde J., and Roig-Escofet D. A comparative study of computed digital absorptiometry and conventional dual-energy x-ray absorptiometry in postmenopausal women. Osteoporosis Int 12 (2001) 565-569
17. Mazzucchelli R., Quirós J., Zarco P., Noheda M., Crespí N., Cabero F., et al. Valor de la densitometría DEXA en falange comparada con la DEXA a nivel de columna lumbar y cadera [resumen]. Rev Esp Reumatol 28 (2001) 181
18. Ibáñez R., Fito C., Gutiérrez R., Del Val N., and Loza E. Correlación entre la densitometría ósea (DEXA) de cadera y columna lumbar con la de falange (ACCUDEXA). Valoración de la densitometría de falange como herramienta diagnóstica o de cribado. Rev Esp Reumatol 31 (2004) 419-424